Analyst Ratings February 12, 2026

DA Davidson Starts Intel Coverage at Neutral, $45 Target Cites Valuation Concerns

Analyst flags ambitious company reset and lofty market pricing despite recent revenue catalysts

By Maya Rios INTC
DA Davidson Starts Intel Coverage at Neutral, $45 Target Cites Valuation Concerns
INTC

DA Davidson initiated coverage of Intel Corporation (INTC) assigning a Neutral rating and a $45.00 price target. The firm's view highlights a major operational reset underway at Intel and recognizes tangible business developments that have driven substantial recent share gains, while warning that current market expectations embedded in the stock appear optimistic.

Key Points

  • DA Davidson started coverage on Intel with a Neutral rating and a $45.00 price target, near the current share price of $46.49 and consistent with the analyst consensus of 2.81 (Neutral).
  • The firm described Intel's transition as a major reset, balancing a rebuild of leading-edge process capabilities with efforts to become a third-party foundry, while acknowledging tangible business developments driving stock gains.
  • Despite strong recent share performance (121.41% over six months; 114.81% over 12 months), DA Davidson cautioned the stock price appears to embed optimistic assumptions and highlighted high valuation multiples such as an EV/EBITDA of 19.39x.

DA Davidson opened coverage of Intel Corporation (NASDAQ: INTC) with a Neutral recommendation and a $45.00 price target, an assessment that sits very near the company's prevailing market price of $46.49. The research house observed that its view broadly aligns with the prevailing analyst consensus, recorded at 2.81 on the same scale - a level that equates to Neutral.

In its initial report, DA Davidson described Intel's corporate transition as "one of the hardest resets in semiconductor history." The firm emphasized that the company is attempting a twofold transformation: rebuilding its leading-edge process technology while simultaneously positioning itself as a reliable third-party foundry for external customers.

Despite the scale of that operational turnaround, the analyst noted there are "real developments across the business for investors to get excited about." Those developments have coincided with substantial market appreciation: Intel's shares have risen 121.41% over the last six months and posted a 114.81% gain over the prior 12 months.

Even with those gains and ongoing initiatives, DA Davidson characterized Intel as the "ultimate 'show me' story," underscoring that the company still needs to demonstrate consistent execution before the cautious viewpoint shifts. That caution is rooted in recent financial performance: Intel was not profitable over the trailing twelve months, although analysts anticipate the firm will return to profitability within the current year.

Valuation entered centrally into DA Davidson's assessment. The firm wrote that the current market price "continues to reflect assumptions we view are all too optimistic." Supporting that concern, InvestingPro data cited by the report shows Intel trading above its Fair Value and carrying relatively high valuation multiples, including an enterprise value to EBITDA multiple of 19.39x.

Beyond DA Davidson's initiation, the report summarized several corporate developments that bear on Intel's strategy and market outlook. The company has announced plans to enter the graphics processing unit (GPU) market and has hired a chief GPU architect to lead that initiative. Intel also revealed a partnership with SoftBank Corp.'s SAIMEMORY to commercialize next-generation Z-Angle Memory (ZAM) technology, aimed at improving processing performance for data centers and AI model training.

Other analyst activity referenced in the report included Tigress Financial Partners raising its Intel price target to $66 while retaining a Buy rating, citing AI data center demand and potential AI-driven PC refresh cycles as growth drivers.

The company has also taken regulatory and contractual steps: Intel filed a resale prospectus supplement with the U.S. Securities and Exchange Commission to update the registration of securities tied to an agreement with the U.S. Department of Commerce; that filing did not involve issuance of new securities.

Finally, the coverage noted a related supply agreement in the broader Intel corporate ecosystem: Mobileye Global Inc. secured a contract to provide advanced driver assistance systems to Mahindra & Mahindra Ltd. for at least six upcoming vehicle models, with production set to begin in 2027. Those systems will be powered by Mobileye's EyeQ6 High system-on-chip and will employ multiple cameras and radar sensors.


Context and implications

The initiation from DA Davidson frames Intel at a crossroads: the company is pursuing complex technical rebuilds and business model shifts while trading at valuations that some analysts view as aggressive. Investors tracking semiconductors, data center technology and AI-related hardware will likely weigh DA Davidson's caution alongside the operational milestones Intel continues to pursue.

Risks

  • Execution risk tied to Intel's extensive operational reset, which affects the semiconductor sector and foundry services market.
  • Profitability uncertainty, given Intel was not profitable over the trailing twelve months and must return to profitability as analysts expect this year; this impacts equity valuation in technology and data center markets.
  • Valuation risk from elevated multiples and trading above Fair Value, which could expose investors in semiconductors and AI hardware to downside if growth or margin expectations are not met.

More from Analyst Ratings

HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026